Free Articles, Free Web Content, Reprint Articles
Tuesday, August 14, 2018
 
Free Articles, Free Web Content, Reprint ArticlesRegisterAll CategoriesTop AuthorsSubmit Article (Article Submission)ContactSubscribe Free Articles, Free Web Content, Reprint Articles
 

Global Ortho And Osteobiologics Market Set To Grow To $6.1bn By 2023

The global Ortho and Osteobiologics market is expected to grow at a CAGR of 5.4% in the first half of the forecast period. In 2017, the Osteoarthritis market accounted for 25% of the Ortho and Osteobiologics market.

LONDON, UK. JANUARY 2018: Visiongain has launched a new pharma report Global Ortho and Osteobiologics Market 2018-2028: Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-rich Protein, Bone Marrow Aspirate, Osteoarthritis, Spinal Fusion, Fracture, Soft Tissue Injury, Hospitals, Clinics, Research and Academic Institutes

The Ortho and Osteobiologics industry has evolved tremendously in recent years with an array of novel technological development being designated to treat orthopaedic disorders. The regulatory authorities such as the U.S. FDA and EMA are streamlining the regulatory process and approving different advanced devices. There is a huge market potential in the developing countries of Asia-Pacific and LAMEA regions, as the healthcare infrastructure, awareness, and affordability have increased in these regions.

The lead analyst of the report commented “Continuous technological innovations in ortho and osteobiologics industry is set to drive the market at an exponential rate. The emergence of natural biomaterials-based ortho and osteobiologics has revolutionized the ortho and osteobiologics industry as these have several advantages compared to synthetic biomaterials.

Competitive rivalry is intense in the Ortho and Osteobiologics market owing to high number of competitors of nearly equal market size and share. Companies competing in the Ortho and Osteobiologics market are continuously putting efforts to gain market share through novel product launches & product approvals owing to the large scope of product differentiation.”

Leading companies featured in the report include Johnson & Johnson (DePuy Synthes), Medtronic PLC, Colson Associates, Inc. (OsteoMed LLC), Arthrex, Inc, Stryker Corporation, Zimmer Biomet Holdings, Inc. (Zimmer Biomet), Smith & Nephew plc, Orthofix International N.V., Skye Osteobiologics Inc., BioVentus.

 

Notes for Editors
If you are interested in a more detailed overview of this reportArticle Search, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

n.

Source: Free Articles from ArticlesFactory.com

ABOUT THE AUTHOR


Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend o



Health
Business
Finance
Travel
Technology
Home Repair
Computers
Marketing
Autos
Family
Entertainment
Law
Education
Communication
Other
Sports
ECommerce
Home Business
Self Help
Internet
Partners


Page loaded in 1.684 seconds